Hemodynamic Monitoring Systems Market to Surpass US$ 1,826.3 Mn by 2030 - Coherent Market Insights

Global Hemodynamic Monitoring Systems Market, by Product Type (Vital Sign Monitors, Pulse Oximeters, Non-Invasive Blood Pressure Monitors, Central Venous Catheters, Pulmonary Artery Catheters), by Application (Invasive Hemodynamic Monitoring, Non-Invasive Hemodynamic Monitoring, Minimally Invasive Hemodynamic Monitoring), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Independent Catheterization Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 1,094.5 Million in 2022 and is expected to exhibit a CAGR of 6.6% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.

The increasing adoption of inorganic strategies such as product launch by key market players is expected to drive the global hemodynamic monitoring systems market over the forecast period. For instance, in January 2021, TytoCare Ltd., a telehealth company, announced that they had launched fingertip Pulse Oximeter (SpO2). Fingertip Pulse Oximeter (SpO2) will help in monitoring blood oxygen saturation level and heart rate remotely and the result will appear on the handheld device and the pulse oximeter adaptor.

Global Hemodynamic Monitoring Systems Market– Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdown in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.

However, the COVID-19 pandemic had a positive impact on the global hemodynamic monitoring systems market, owing to the increasing funding by the government. For instance, in March 2021, Koninklijke Philips N.V., a health technology company, announced that they had increased the production of critical care products that includes vital sign monitors for COVID-19. This increased production will help in diagnosis and treatment of COVID-19 patients by vital signs monitoring that provide information to the medical and nursing staff about the physiologic condition of the patient.

Global Hemodynamic Monitoring Systems Market: Key Developments

Adoption of inorganic strategies such as product launch by key market players is expected to drive the global hemodynamic monitoring systems market over the forecast period. In October 2020, Getinge AB., a medical technology company, announced that they had launched NICCI, the latest innovative advanced hemodynamic monitoring system. NICCI will provide continuous and noninvasive hemodynamic insights to reduce the risk of severe complications for patients with low blood pressure, it will also provide the information about cardiac index (CI), stroke volume variation (SVV) and pulse pressure variation.

Browse 33 Market Data Tables and 35 Figures spread through 180 Pages and in-depth TOC on “Global Hemodynamic Monitoring Systems Market”-  Forecast to 2030, Global Hemodynamic Monitoring Systems Market, by Product Type (Vital Sign Monitors, Pulse Oximeters, Non-Invasive Blood Pressure Monitors, Central Venous Catheters, Pulmonary Artery Catheters), by Application (Invasive Hemodynamic Monitoring, Non-Invasive Hemodynamic Monitoring, Minimally Invasive Hemodynamic Monitoring), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, Independent Catheterization Laboratories), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/hemodynamic-monitoring-systems-market-1070

Moreover, increasing adoption of inorganic strategies such as product approval by regulatory authorities such as the U.S. Food and Drug Administration is expected to drive the market over the forecast period. For instance, in July 2020, Nonin, a manufacturer of noninvasive patient monitoring devices, announced that they had received the U.S. Food and Drug Administration clearance for a hand-held vital sign monitor, which is designed to assess patients suffering from a heart attack or physical injury, as well as those affected by carbon monoxide poisoning and smoke inhalation by tracking a person’s blood oxygen levels and pulse rate.

Key Takeaways of the Global Hemodynamic Monitoring Systems Market:

• The global hemodynamic monitoring systems market is expected to exhibit a CAGR of 6.6% during the forecast period due to the increasing adoption of inorganic strategies such as acquisition by the key market players. For instance, in April 2019, Edwards Lifesciences Corporation, a medical technology company announced that they had acquired CAS Medical Systems, Inc., a medical technology company. Under this acquisition, Edwards Lifesciences Corporation acquired CASMED's FORE-SIGHT non-invasive cerebral oxygenation technology and paired it with the HemoSphere advanced hemodynamic monitoring platform, which will offer an enhanced recovery tool and predictive analytics capabilities for clinicians.
• Among product type, vital sign monitors segment is estimated to hold a dominant position in the global hemodynamic monitoring systems market due to increasing inorganic strategies such as product launch over the forecast period. For instance, in March 2021, Nonin, a manufacturer of noninvasive patient monitoring devices, announced that they had launched two new vital sign monitoring product, a single-use wristband and a sensor for use with Nonin’s wristOx2 3150 wrist-worn pulse oximeter. It will help for pulse oximetry and pulse rate monitoring.
• among regions, North America is estimated to account for the largest market share in the global hemodynamic monitoring systems market, owing to the increasing adoption of inorganic strategies such as product launch by key market players in that region. For instance, in October 2021, Nihon Kohden Corporation, a manufacturer of medical electronic equipment, announced that they had launched NK-HealthProtect in the U.S. to help health professionals during COVID-19. NK-HealthProtect will provide vital signs monitoring of multiple patients on a single screen, and faster recognition when vital signs change.
• Major players operating in the global hemodynamic monitoring systems market include Edwards Lifesciences Corporation, ICU Medical, Inc., PULSION Medical Systems SE, Koninklijke Philips N.V., General Electric, TytoCare Ltd., Getinge AB., Nonin, Masimo, Baxter, OMRON Corporation, B. Braun Melsungen AG, Medtronic, Dragerwerk AG & Co. KGaA, Nihon Kohden Corporation, Schwarzer Cardiotek GmbH, Osypka Medical GmbH, and Tensys Medical Inc.